BIO-RAD LABORATORIES, INC. - CL A (BIO)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
18.8M
Holdings value Q3 2024
$6.3B
Value change Q3 2024
-$392M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
424
Number of buys Q3 2024
188
Number of sells Q3 2024
-227
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 18.8M $6.3B -$392M $334.58 425
2024 Q2 19.8M $5.41B +$464M $273.11 425
2024 Q1 17.9M $6.2B -$152M $345.87 451
2023 Q4 18.5M $5.98B -$32.7M $322.89 472
2023 Q3 18.5M $6.64B -$145M $358.45 458
2023 Q2 18.3M $6.93B -$177M $379.12 457
2023 Q1 19.2M $9.17B +$16.8M $479.02 492
2022 Q4 19.2M $8.08B -$119M $420.49 462
2022 Q3 19.4M $8.11B +$111M $417.14 466
2022 Q2 19.1M $9.44B +$35.2M $495.00 487
2022 Q1 19.1M $10.8B -$34.4M $563.23 498
2021 Q4 19.1M $14.4B -$387M $755.57 516
2021 Q3 19.3M $14.4B +$60.8M $745.95 496
2021 Q2 19.3M $12.4B -$126M $644.29 492
2021 Q1 19.6M $11.2B -$10.2M $571.17 479
2020 Q4 19.7M $11.4B +$301M $582.94 483
2020 Q3 19.3M $9.93B +$29.3M $515.46 472
2020 Q2 19.2M $8.67B +$212M $451.49 460
2020 Q1 18.8M $6.6B -$18.4M $350.56 398
2019 Q4 18.9M $6.99B -$73.8M $370.03 380
2019 Q3 19.2M $6.4B +$148M $332.74 349
2019 Q2 18.7M $5.84B -$162M $312.59 328
2019 Q1 19.4M $5.94B +$26.5M $305.68 342
2018 Q4 19.1M $4.43B -$63.7M $232.22 320
2018 Q3 18.9M $5.92B +$12.2M $312.99 335
2018 Q2 19.1M $5.51B -$51.8M $288.54 320
2018 Q1 19.3M $4.82B +$32.3M $250.08 309
2017 Q4 19.2M $4.58B +$6.18M $238.67 298
2017 Q3 19.2M $4.26B +$85M $222.22 271
2017 Q2 18.8M $4.26B -$40.1M $226.31 274
2017 Q1 19M $3.8B +$209M $199.34 270
2016 Q4 19.7M $3.59B +$100M $182.28 254
2016 Q3 19.1M $3.12B -$2.04M $163.81 235
2016 Q2 18.8M $2.69B +$70.2M $143.02 230
2016 Q1 18.3M $2.5B -$31M $136.72 225
2015 Q4 18.5M $2.57B -$16.3M $138.66 236
2015 Q3 18.8M $2.53B +$40.7M $134.31 241
2015 Q2 18.7M $2.81B -$21.2M $150.61 221
2015 Q1 18.9M $2.55B +$11.1M $135.18 213
2014 Q4 18.8M $2.27B +$15.4M $120.56 210
2014 Q3 18.4M $2.09B +$35.4M $113.40 198
2014 Q2 18.3M $2.19B +$17.3M $119.71 201
2014 Q1 18.1M $2.31B -$21.7M $128.12 188